Milford Funds’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.9M Buy
53,305
+28,544
+115% +$29.2M 1.04% 30
2026
Q1
$22.8M Sell
24,761
-7,985
-24% -$8.1M 0.48% 47
2025
Q4
$35.2M Buy
+32,746
New +$31.3M 0.69% 44

Other funds holding LLY

Milford Funds's LLY Position: Q2 2026 in Review

Milford Funds increased its Eli Lilly (LLY) stake by 115% in Q2 2026, buying an estimated $29.2M and bringing the position to 53,305 shares worth $63.9M. The position accounts for 1.04% of the portfolio, ranked #30.

Milford Funds first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Milford Funds held 53,305 shares of Eli Lilly worth $63.9M as of Q2 2026.
  • Milford Funds bought 28,544 Eli Lilly shares in Q2 2026, an estimated $29.2M.
  • Eli Lilly made up 1.04% of Milford Funds's portfolio in Q2 2026, its #30 holding.
  • Milford Funds first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Milford Funds's 13F filing for Q2 2026, filed 30 Jul 2026.